Health Condition 1: N819- Female genital prolapse, unspecified Health Condition 2: M179- Osteoarthritis of knee, unspecified
Conditions
Interventions
Intervention1: Inj Hyperbaric Levobupivacaine: 15 mg of 0.5% inj hyperbaric levobupivacaine+ inj buprenorphine (2mcg/kg) for spinal anaesthesia
Control Intervention1: Inj Hyperbaric bupivacaine: 15mg
Sponsors
Dr Kalaivani S
Eligibility
Inclusion criteria
Inclusion criteria: 1)American society of Anaesthesiologists(ASA) physical status classification 1 and 2. 2) scheduled for elective infraumbilical surgeries under regional anaesthesia 3)patients with valid informed consent
Exclusion criteria
Exclusion criteria: 1)Patient refusal for regional anaesthesia 2)emergency infraumbilical surgeries 3)patients having hypersensitivity to any of the study drugs 4)patients with spinal deformities 5)preexisting neurological diseases like lower extremity neuropathy 6)intrinsic or idiopathic coagulopathy 7)skin or soft tissue infection at proposed site of needle insertion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare difference in systolic blood pressure between two study groupsTimepoint: to check for blood pressure every 5 minutes once until the end of surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Degree of motor blockade achievedTimepoint: degree of motor blockade checked every 2 minutes upto 10 minutes after spinal anaesthesia;onset of sensory blockTimepoint: sensory level checked every 2 minutes upto 10 minutes after spinal anaesthesia;total duration of analgesiaTimepoint: to check the total duration of analgesia achieved after spinal anaestheia | — |
Countries
India
Contacts
Public ContactDr Pushpavathi S H
Karnataka institute of medical sciences
Outcome results
None listed